pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • FLUDEOXYGLUCOSE F18
    FLUDEOXYGLUCOSE F18
    no indication UNIV MICHIGAN
  • FLUDROCORTISONE ACETATE
    FLUDROCORTISONE ACETATE
    no indication IMPAX LABS
  • FLUOCINOLONE ACETONIDE TOPICAL
    FLUOCINOLONE ACETONIDE TOPICAL
    no indication ACTAVIS LABS UT INC
  • FLUOCINOLONE ACETONIDE TOPICAL SOLUTION USP, 0.01%
    FLUOCINOLONE ACETONIDE TOPICAL SOLUTION USP, 0.01%
    no indication
← prev
page 85 of 231
next →
131
Pain89
Neurology1
ENCUBE ETHICALS
  • FLUORESCITE
    FLUORESCITE (FLUORESCEIN SODIUM)
    no indication ALCON LABS INC
  • FLUOXETINE
    FLUOXETINE
    no indication MICRO LABS
  • FLUOXETINE HCL
    FLUOXETINE HCL
    no indication STRIDES PHARMA
  • FLUTICASONE PROPIONATE AND SALMETEROL
    FLUTICASONE PROPIONATE AND SALMETEROL
    no indication TEVA PHARM
  • FLUVASTATIN
    FLUVASTATIN
    no indication TEVA PHARMS
  • Preclinical
    FMC-220
    Solid Tumor LG Chem Ltd
  • Phase 1
    FMT-XBI-302
    Graft Versus Host Disease (GVHD) Shenzhen UnknownBio Biotechnology Co Ltd
  • Preclinical
    FN-2012
    Idiopathic Pulmonary Fibrosis Faknostics LLC
  • FOAMING HAND WASH
    FOAMING HAND WASH (CHLORHEXIDINE GLUCONATE)
    no indication XTTRIUM
  • Preclinical
    FORCEM-23D
    Duchenne Muscular Dystrophy$DYN Dyne Therapeutics, Inc.
  • Phase 1
    FORX-428
    Metastatic Breast Cancer FoRx Therapeutics AG
  • FOSAPREPITANT
    FOSAPREPITANT
    no indication DR REDDYS
  • FOSTER AND THRIVE ALLERGY AND CONGESTION D
    FOSTER AND THRIVE ALLERGY AND CONGESTION D (FEXOFENADINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE)
    no indication L PERRIGO CO
  • Preclinical
    FP-016
    Unspecified Neurologic Disorders Foresee Pharmaceuticals Co Ltd
  • Preclinical
    FP-017
    Unspecified Neurologic Disorders Foresee Pharmaceuticals Co Ltd
  • Preclinical
    FP-0210
    no indication Formosa Pharmaceuticals Inc
  • Phase 2
    FP-101
    Vasomotor Symptoms of Menopause (Hot Flashes) Fervent Pharmaceuticals LLC
  • Phase 1
    FPI-2068
    Metastatic Colorectal Cancer Fusion Pharmaceuticals Inc
  • Phase 2
    FPI-2265
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Fusion Pharmaceuticals Inc
  • Phase 1
    FS-120
    Advanced Malignancy invoX Pharma Ltd
  • Preclinical
    FT-002a-O
    Castration-Resistant Prostate Cancer (CRPC) AecorBio Inc
  • Phase 1
    FT-522
    B-Cell Non-Hodgkin Lymphoma$FATE FATE THERAPEUTICS INC
  • Phase 1
    FT-576
    Refractory Multiple Myeloma$FATE FATE THERAPEUTICS INC
  • Phase 1
    FT-819
    Idiopathic Inflammatory Myopathy (IIM)$FATE FATE THERAPEUTICS INC
  • Phase 1
    FT-825
    Colorectal Cancer$FATE FATE THERAPEUTICS INC
  • Phase 1
    FT-836
    Breast Cancer$FATE FATE THERAPEUTICS INC